Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Order Your Article Before Print

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a free, quick track basis, to ensure timely review and publication of much needed research

Contents

Current Drug Targets, Volume 14 - Number 7


Therapeutic Prospects of PPARs in Psychiatric Disorders: A Comprehensive Review

, 14(7): 724 - 732

Benjamin Rolland, Julie Deguil, Renaud Jardri, Olivier Cottencin, Pierre Thomas and Regis Bordet


DOI: 10.2174/1389450111314070002




PPARs: A Potential Target for a Disease-Modifying Strategy in Stroke

, 14(7): 752 - 767

Thavarak Ouk, Camille Potey, Sophie Gautier, Michele Bastide, Dominique Deplanque, Bart Staels, Patrick Duriez, Didier Leys and Regis Bordet


DOI: 10.2174/1389450111314070005




Cyclization in Opioid Peptides

, 14(7): 798 - 816

Justyna Piekielna, Renata Perlikowska, Katarzyna Gach and Anna Janecka


DOI: 10.2174/1389450111314070008




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63

Advertisement

Coronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog